ATP2B1, ATPase plasma membrane Ca2+ transporting 1, 490
N. diseases: 57; N. variants: 23
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Eye Diseases | Acquired Abnormality | 878 | 124 | 0.300 | None | 1.000 | 1 | 2004 | 2004 | |||||
|
phenotype | Eye Diseases | Finding | 24 | 0.300 | None | 1.000 | 1 | 2004 | 2004 | ||||||
|
disease | Eye Diseases | Disease or Syndrome | 28 | 0.300 | None | 1.000 | 1 | 2004 | 2004 | ||||||
|
phenotype | Behavior and Behavior Mechanisms | Individual Behavior | 210 | 535 | 0.100 | None | 1.000 | 1 | 5 | 2018 | 2018 | ||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 1499 | 201 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||
|
phenotype | Laboratory Procedure | 138 | 216 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Finding | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 545 | 1440 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 89 | 111 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
group | Nervous System Diseases; Cardiovascular Diseases | Disease or Syndrome | 1658 | 591 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||
|
phenotype | Organism Attribute | 565 | 1138 | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||
|
phenotype | Laboratory Procedure | 563 | 1418 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 23 | 71 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||
|
group | Nutritional and Metabolic Diseases; Endocrine System Diseases | Disease or Syndrome | 2803 | 824 | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||
|
disease | Endocrine System Diseases | Disease or Syndrome | 2359 | 710 | 0.100 | None | 1.000 | 1 | 2 | 2016 | 2016 | ||||
|
disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 939 | 584 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||
|
phenotype | Laboratory Procedure | 486 | 1243 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 1756 | 711 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||
|
phenotype | Clinical Attribute | 1014 | 2689 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||
|
disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases | Disease or Syndrome | 1410 | 80 | 0.010 | None | 1.000 | 1 | 2020 | 2020 | |||||
|
disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Endocrine System Diseases | Disease or Syndrome | 24 | 35 | 0.010 | None | 1.000 | 1 | 1985 | 1985 | |||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 47 | 14 | 0.010 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||
|
group | Neoplasms; Skin and Connective Tissue Diseases | Neoplastic Process | 2780 | 385 | 0.010 | None | 1.000 | 1 | 2005 | 2005 | |||||
|
disease | Neoplasms | Neoplastic Process | 517 | 12 | 0.010 | None | 1.000 | 1 | 2002 | 2002 |